About 384,000 results
Open links in new tab
  1. Home | Introducing Keenova and Par Health

    On July 31, 2025, Mallinckrodt and Endo joined together to better serve patients and customers with a bold plan for the future.

  2. MNK Group - Our Story

    Founded in 2009 as MNK Re, the MNK Group has grown from a Lloyd’s of London broking house to a group of insurance and reinsurance companies and an MGA platform spanning the globe.

  3. Mallinckrodt | MNK Stock Price, Company Overview & News - Forbes

    Mallinckrodt Plc operates as a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical …

  4. MNK Group Unifies Under One Brand Name - insurance-edge.net

    Apr 7, 2025 · MNK Group has entered a new phase of growth with the launch of its unified brand, which integrates its broking, MGA, and risk-taking entities to ensure a consistent customer …

  5. MNK renames Lloyd's broker under unified brand

    Apr 4, 2025 · MNK Group said it plans to continue growing organically, as well as through acquisition, with several M&A deals involving broking and insurance carriers in the pipeline.

  6. MNK Clothing | Kohl's

    Find great deals on MNK Clothing at Kohl's today!

  7. Mallinckrodt Pharmaceuticals - LinkedIn

    Mallinckrodt Pharmaceuticals combined with Endo in 2025 to better serve customers and improve outcomes for the patients we support.

  8. Mallinckrodt PLC Stock (MNK) - Quote OTC Markets

    Mallinckrodt PLC (MNK:): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Mallinckrodt PLC | OTC Markets: MNK | OTC Markets

  9. MNK - MNK Latest Stock News & Market Updates

    Nov 12, 2025 · Stay updated with Mallinckrodt plc (MNK) news: Earnings reports, regulatory updates, and specialty pharmaceutical developments for investors and healthcare professionals.

  10. MNK Proteins as Therapeutic Targets in Leukemia - PMC

    MNKs are kinases involved in cancer promoting and cancer cell survival signaling. Preclinical evidence, especially using MNK inhibitors in combination with chemotherapy or other targeted …